Information taken from http://www.kempharm.com/pages/company/management-team.php
As Executive Vice President, Government and Public Relations, Mr. Cohen is responsible for leading KemPharm’s public policy and public communications strategies. With nearly 40 years’ experience, Mr. Cohen is widely regarded as an influential thought leader in the abuse deterrent formulation (ADF) industry, currently serving as the Forum Chair of the Abuse Deterrent Coalition, representing nearly 30 ADF manufacturers, patient advocates and related organizations seeking to expand access to ADF technologies. In addition, he is the Vice Chairman of the Board of Directors for the MedStar National Rehabilitation Hospital Network, a 129 bed, $105m annual revenue specialty hospital.
Prior to joining KemPharm, Mr. Cohen was the consulting Head of North American Government Relations for Grünenthal USA, a biopharmaceutical company that is developing abuse deterrent formulations for opioid analgesics, and was Senior Vice President of Government Relations and Health Policy with the obesity medical device manufacturer, EnteroMedics, Inc. During his tenure at EnteroMedics, Mr. Cohen was part of the senior management team that led the successful 2015 FDA approval of the first new obesity medical device for consumer health since 2001.
Mr. Cohen has worked in Washington, D.C. since 1979 and has led legislative policy and governmental regulatory relations programs for multiple companies and organizations, managing public policy, investor relations, and political functions at the state, national and global levels. Career highlights include serving as Managing Director, Global Government Relations for The Depository Trust & Clearing Corporation, as the senior legislative liaison for the American Israel Public Affairs Committee (AIPAC), an Alternate Delegate of the United States to the United Nations, and earlier served as Legislative Director for two Congressmen on Capitol Hill and in various campaign positions at the Presidential, Congressional, State and local levels. He has held senior executive positions with several medical device and healthcare corporations, including US Oncology, Allergan Corporation, and Inamed Corp (acquired by Allergan in 2006).
Mr. Cohen earned a bachelor’s degree in Sociology from Willamette University and received a master’s degree in International Affairs from Georgetown University.